May 18, 2011 - The Society for Imaging Informatics in Medicine (SIIM) announces tools and training to help medical informaticsprofessionals stay competitive in a rapidly changing environment. SIIM will provide fundamental, up-to-date education and solutions essential for imaging informatics professionals (IIPs) and their organizations at the society's 2011 annual meeting, June 2-5, in Washington, D.C./National Harbor, Md.

May 18, 2011 – The world’s first system to integrate the functional and anatomical modalities of fractional flow reserve (FFR) and optical coherence tomography (OCT) into one platform will be highlighted by St. Jude Medical at the Paris Course on Revascularization (EuroPCR) 2011.

May 17, 2011 - Medrad Inc., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocathtechnology. The Cotavance catheter is used in percutaneous interventions for the treatment of peripheral arterial disease (PAD) and is approved for balloon dilation of stenotic lesions in the iliac and infrainguinal arteries while applying paclitaxel to the vessel wall to inhibit restenosis. Medrad Interventional has started selling its Cotavance catheter in countries where it has already received regulatory approval, including select European and Middle East countries. The announcement was made in conjunction with the Congress of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) in Paris.

May 16, 2011 - Cordis announces the launch in Europe of Radial Solutions, a complete portfolio for transradial interventions. New to the portfolio is the Cordis Radialsource Transradial Access Kit. Radialsource Transradial Sheaths are designed to provide physicians with atraumatic and smooth access to the radial artery during diagnostic and interventional procedures.

May 16, 2011 - The German Supreme Court (BGH) declared a structural heart occluder patent case to be invalid. In the ruling by the BGH, the court does not see any basis for AGA/St. Jude's claim that the Occlutech atrial septal defects and patent foramen ovale (ASD and PFO) occluders violate any patent brought forward in the litigation and declares earlier German ruling to the contrary invalid.

May 16, 2011 - The first patient was recently enrolled in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study to determine the safety and efficacy of BioControl Medical’s CardioFit system. The implantable electrical stimulation device is designed to improve heart function in patients with congestive heart failure (HF). The first patient was enrolled at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.

May 11, 2011 - Micell Technologies announced that positive preclinical data will be presented at the EuroPCR conference regarding the MiStent Drug-Eluting Coronary Stent System (MiStent DES), an ultra-thin, advanced alloy drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation. The data will be presented in Paris, France on May 18, 2011 in a presentation titled "MiStent DES: A Novel Third Generation DES with a Fully-absorbable Coating and Enhanced Drug Delivery Capabilities."